Form 8-K - Current report:
SEC Accession No. 0001903596-24-000552
Filing Date
2024-08-22
Accepted
2024-08-22 16:15:12
Documents
15
Period of Report
2024-08-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 kays_8k.htm   iXBRL 8-K 28090
2 ex3_1.htm EX-3.1 409
3 GRAPHIC ex3_1.jpg GRAPHIC 283909
  Complete submission text file 0001903596-24-000552.txt   591246

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE kays-20240822.xsd EX-101.SCH 3027
5 XBRL LABEL FILE kays-20240822_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE kays-20240822_pre.xml EX-101.PRE 22367
17 EXTRACTED XBRL INSTANCE DOCUMENT kays_8k_htm.xml XML 3588
Mailing Address 915 MIDDLE RIVER DRIVE, SUITE 316 FORT LAUDERDALE FL 33304
Business Address 915 MIDDLE RIVER DRIVE, SUITE 316 FORT LAUDERDALE FL 33304 954-5347895
Kaya Holdings, Inc. (Filer) CIK: 0001530746 (see all company filings)

EIN.: 900898007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-177532 | Film No.: 241232164
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)